Partial breast irradiation with CyberKnife after breast conserving surgery: a pilot study in early breast cancer

RT @Accuray: The results of this pilot study “showed the safe feasibility of #CyberKnife-APBI in early breast cancer, with mild acute and l…

Check out the abstract released during #ASTRO20!

RT @Accuray_Fr: Les résultats de cette étude montrent la faisabilité de l’irradiation partielle accélérée du sein par #radiothérapie #stéré…

Les résultats de cette étude montrent la faisabilité de l’irradiation partielle accélérée du sein par #radiothérapie #stéréotaxique dans le #cancerdusein précoce, avec une légère toxicité aiguë tardive et de très bons résultats cosmétiques #ASTRO20 #radonc

The results of this pilot study “showed the safe feasibility of #CyberKnife-APBI in early breast cancer, with mild acute and late toxicity and very good cosmetic results." #bcsm #AccurayExpandRT #ASTRO20 Read it here: https://t.co/DPlAtR1ju8 https://t.co/B

Preliminary results from @IstTumori in Italy, showed the safety and feasibility of #CyberKnife APBI in early #breastcancer with mild acute and late toxicity and very good cosmetic results. #Accuray #RadOnc Full abstract here: https://t.co/mqk9W8AzmS https:

Partial breast irradiation with CyberKnife after breast conserving surgery: a pilot study in early breast cancer https://t.co/zPusdkBfw4